US Stock MarketDetailed Quotes

IOVA Iovance Biotherapeutics

Watchlist
  • 5.650
  • +0.090+1.62%
Close Feb 19 16:00 ET
  • 5.689
  • +0.039+0.69%
Post 19:58 ET
1.72BMarket Cap-3.82P/E (TTM)

Iovance Biotherapeutics Key Stats

Iovance Biotherapeutics Q4 2024 Estimates Date

Currency:USDFeb 27, 2025

Estimate YoY
Revenue
72.17M
+14873.88%
EPS
-0.27
+39.74%
Strong Buy

Feb 13, 2025

Iovance Biotherapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 86.485M--
Feb 27, 20252024/Q4-- / 72.174M--
Nov 7, 20242024/Q358.555M / 53.818M--
Aug 8, 20242024/Q231.106M / 24.561M--
May 9, 20242024/Q1715.000K / 2.088M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 86.485M--
Feb 27, 20252024/Q4-- / 72.174M--
Nov 7, 20242024/Q358.555M / 53.818M--
Aug 8, 20242024/Q231.106M / 24.561M--
May 9, 20242024/Q1715.000K / 2.088M--

Unlock Free Earnings Estimates

Iovance Biotherapeutics Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Feb 13, 2025

Strong Buy

  • Buy

    85.71%
  • Hold

    14.29%
  • Sell

    0.00%

Price Target

No Data